cancer doctors

Lung Cancer

Question: How long does it take lung cancer to form? My 37 year old sister has two masses of incurable cancer on each lung. It is inoperable. I am just curious. How long did she have it. 1 year, 2 years? I just wonder how long she was walking around with cancer not even knowing it. Thank for any help. She is to young to die.

Answer: lung cancer has an 11% surival rate, so she most likely will die. Sorry


Lung Cancer News

Merck KGaA Doesn't Rule Out Pursuing Lung-Cancer Vaccine

Bloomberg
Non-small cell lung cancer is the most common form of the disease and most people diagnosed with it are at an advanced stage, the company said. L-BLP25 is a therapeutic vaccine which is designed to stimulate a patient's immune system to identify and ...
 

Times of Oman

FDA approves genetic test for lung cancer drug - USA Today
USA TODAY
 

WDTV

Health Alert: Lung Cancer Part 4
WDTV
 

Roche Wins FDA Approval for Test to Target Lung Cancer

Bloomberg
Non-small cell lung cancer accounts for 85 percent of lung cancers, the FDA said. About 228,190 people will be diagnosed with lung cancer in the U.S. this year and 159,480 patients will die of the disease, according to the National Cancer Institute ...
 

Understanding lung cancer [Infographic] - Milwaukee Journal Sentinel

Milwaukee Journal Sentinel
Too often, the follow-up question to learning a person has been diagnosed with lung cancer is, "Does he or she smoke?" In fact, anyone can get lung cancer whether they are young or old, male or female, have smoked in the past, smoke now or have never ...
 

Lung Cancer Rx Better than Chemotherapy

dailyRx
The US Food and Drug Administration (FDA) has approved Tarceva tablets for the initial treatment of metastatic (has spread) non-small cell lung cancer (NSCLC) tumors with EGFR mutations that have been detected by a new test, which the FDA has also ...
 

Medscape

Chapter Closed on Higher-Dose Radiation for Lung Cancer - Medscape
Medscape
 

ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine

TheStreet.com
SEATTLE (TheStreet) -- New details about failed lung cancer immunotherapy from Oncothyreon (ONTY) were revealed for the first time Wednesday night in a research abstract for the American Society of Clinical Oncology (ASCO) annual meeting. Stimuvax ...
 

Roche wins new targeted OK for Tarceva in EGFR-positive lung cancer

FiercePharma
Roche's ($RHHBY) targeted-drug crusade marches on. Along with its partner, Astellas, the company won FDA approval for a new, first-line use for its lung cancer drug Tarceva in patients whose cancers test positive for specific mutations of the EGFR gene.
 

Oncothyreon reports mixed results in lung cancer drug test

Puget Sound Business Journal (Seattle) (blog)
Oncothyreon Inc. reported mixed results from a test of its drug aimed at non-small cell lung cancer (NSCLC). The Seattle biotech (NASDAQ: ONTY) said in a test of its L-BLP25 (which it formerly called Stimuvax) drug, conducted by Merck Serono, a ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer